» Articles » PMID: 26371

A Comparison of Four Beta-adrenoceptor Antagonists in Patients with Asthma

Overview
Specialty Pharmacology
Date 1978 May 1
PMID 26371
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

1 Cardiovascular and airways response to two non-cardioselective beta-adrenoceptor blocking drugs, propranolol and pindolol (with partial agonist activity) and two cardioselective beta-adrenoceptor blocking drugs, acebutolol (with partial agonist activity) and atenolol, were compared in twelve patients with asthma. 2 All four drugs produced a significant reduction in resting pulse rate and prevented the increase in heart rate following inhaled isoprenaline (1,500 microgram). 3 Seven patients in clinical remission showed no significant bronchoconstrictor response to any of the drugs. In the remaining five patients, bronchoconstriction was greatest following propranolol (mean reduction in FEV1 26.6%) and least following atenolol (mean reduction in FEV1 6.5%). 4 The bronchodilator response to inhaled isoprenaline was blocked by propranolol and pindolol but not by acebutolol and atenolol. 5 Partial agonist activity did not appear to be clinically useful.

Citing Articles

Exploring the kinetic selectivity of drugs targeting the β -adrenoceptor.

Sykes D, Jimenez-Roses M, Reilly J, Fairhurst R, Charlton S, Veprintsev D Pharmacol Res Perspect. 2022; 10(4):e00978.

PMID: 35762357 PMC: 9237807. DOI: 10.1002/prp2.978.


Comorbidity of asthma and hypertension may be mediated by shared genetic dysregulation and drug side effects.

Zolotareva O, Saik O, Konigs C, Bragina E, Goncharova I, Freidin M Sci Rep. 2019; 9(1):16302.

PMID: 31705029 PMC: 6841742. DOI: 10.1038/s41598-019-52762-w.


Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptors.

Cleveland K, Liang S, Chang A, Huang K, Chen S, Guo L PLoS One. 2019; 14(5):e0217038.

PMID: 31107911 PMC: 6527222. DOI: 10.1371/journal.pone.0217038.


Guidance on the diagnosis and management of asthma among adults in resource limited settings.

Kirenga B, Schwartz J, de Jong C, van der Molen T, Okot-Nwang M Afr Health Sci. 2016; 15(4):1189-99.

PMID: 26958020 PMC: 4765426. DOI: 10.4314/ahs.v15i4.18.


Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic review.

Huber M, Wacker M, Vogelmeier C, Leidl R PLoS One. 2015; 10(4):e0123292.

PMID: 25875204 PMC: 4405814. DOI: 10.1371/journal.pone.0123292.


References
1.
Paterson J . Beta-adrenergic blocking drugs. Br Med J. 1971; 2(5762):652. PMC: 1796537. DOI: 10.1136/bmj.2.5762.652-b. View

2.
Gayrard P, Orehek J, CHARPIN J . [Propronolol test: new asthma provocation test. Comparative study]. Rev Tuberc Pneumol (Paris). 1971; 35(5):511-22. View

3.
Davidson C, Thadani U, Singleton W, Taylor S . Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment. Br Med J. 1976; 2(6026):7-9. PMC: 1687675. DOI: 10.1136/bmj.2.6026.7. View

4.
Zaid G, Beall G . Bronchial response to beta-adrenergic blockade. N Engl J Med. 1966; 275(11):580-4. DOI: 10.1056/NEJM196609152751103. View

5.
MacDonald A, McNeill R . A comparison of the effect on airway resistance of a new beta blocking drug, ICI.50,172 and propranolol. Br J Anaesth. 1968; 40(7):508-10. DOI: 10.1093/bja/40.7.508. View